ACROBiosystems

ACROBiosystems (Baipusaisi) is a platform-based cornerstone enterprise providing key biological reagent products and solutions for the biomedical and health industry. It is committed to providing better products and solutions for global biomedical companies, biotechnology companies, in vitro diagnostics companies, and scientific research institutions in the research and production of biological drugs, cell immunotherapy, and diagnostic products. The company operates globally, with offices, R&D centers, and production bases in multiple locations in China and the United States. It has obtained ISO9001 certification for management systems and ISO13485 certification for quality management systems of medical devices; some products have completed FDA DMF (Drug Master File) filing confirmation in the United States, greatly facilitating the drug registration work of pharmaceutical R&D personnel. The company went public on October 18, 2021. It currently has over 2,000 critical reagent products and technical service items, mainly including drug target proteins, antibodies, kits, and bioanalytical detection solutions, applied in drug screening and optimization, preclinical experiments, clinical trials, drug production processes and process control (CMC), diagnostic reagent development and optimization for diseases such as cancer, autoimmune diseases, cardiovascular diseases, and infectious diseases in all R&D and production stages. The company has over 5,000 customers in more than 60 countries, with collaborations established with the top 20 pharmaceutical companies globally, and coverage of 80% of the top 50 pharmaceutical companies worldwide, maintaining long-term, stable, and good cooperative relationships. Partners include Pfizer, Roche, Sanofi, Novartis, Merck, GSK, Lilly, Bayer, Hengrui Medicine, BeiGene, Sinovac, CSPC, Innovent, Luye Pharma, etc. The company has gathered outstanding talents from home and abroad in the fields of structural biology and the biomedical industry, with over 25% in R&D, of which more than 90% hold master's or doctoral degrees. Here, you will receive continuous and professional learning and development; have a NICE BOSS and a team that collaborates and is willing to develop together; access diversified career development channels and platforms; enjoy Beijing household registration (for outstanding candidates), work residence permit; competitive compensation system (full social insurance and housing fund, performance bonus, year-end bonus); comprehensive welfare benefits (supplementary commercial medical insurance, free lunch and dinner, statutory annual leave, paid sick leave, rank leave, white-collar apartments, holiday benefits, family visit allowance); and colorful after-work activities (union activities, afternoon tea).